Fenwick & West LLP represented Amyris (NASDAQ: AMRS), a leading integrated industrial biotechnology company, in its entry into a $50 million At Market Issuance Sales Agreement with FBR Capital Markets & Co. and MLV & Co. LLC as Agents.

The Fenwick transaction team included corporate partner Daniel Winnike and corporate associates Faisal Rashid, Priscila Bastazin, Ryan McRobert and Travis Robertson.

Login

Don’t have an account yet?

Register